参考文献/References:
[1]张世红,史森,杨小冉.健康医疗大数据应用面临的挑战及策略探讨[J].中国卫生信息管理杂志,2018,15(6):629-632,658.[2]陈金东.中国各类癌症的发病率和死亡率现状及发展趋势[J].遵义医学院学报,2018,41(6):653-662.[3]曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2021,13(3):63-69.[4]赫捷,李霓,陈万青,等.中国肺癌筛查与早诊早治指南(2021,北京)[J].中国肿瘤,2021,30(2):81-111.[5]武江朋.基于血液检测数据的计算机辅助医疗诊断系统构建[D].兰州:兰州大学,2020.[6]朝乐门.数据科学理论与实践[M].北京:清华大学出版社,2019.[7]邢昕,廖永德,唐和孝,等.肺癌的性别差异及机制[J].中国肺癌杂志,2011,14(7):625-630.[8]王晓东,王超,左风云,等.基于蒙古族农牧民高血压大数据的可视化分析与机器学习算法应用比较研究[J].中国数字医学,2019,14(11):24-28.[9]林青凤,陈洁,张宇虹,等.聚乙二醇化重组人粒细胞刺激因子预防肺癌化疗后白细胞减少的临床研究[J].中国临床医生杂志,2020,48(12):1423-1426.[10]王文,吴小军.以高热、白细胞升高为主要临床表现的肺癌1例及文献复习[J].临床肺科杂志,2015,20(10):1930-1932.[11]Tripathi SC,Peters HL,Taguchi A,et al.Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome[J].Proc Natl Acad Sci U S A,2016,113(11):E1555-E1564.[12]马鸣,赵连梅,杨兴肖,等.痰热清注射液可增强Lewis肺癌化疗小鼠的免疫功能[J].细胞与分子免疫学杂志,2015,31(3):297-301.[13]符少娘,林青,杨威,等.康艾注射液对非小细胞肺癌患者细胞、体液及红细胞免疫状态的影响研究[J].肿瘤药学,2017,7(4):431-435.[14]章成志,谢雨欣,宋云天.学术文本中细粒度知识实体的关联分析[J].图书馆论坛,2021,41(3):12-20.[15]李海林,龙芳菊.基于同步频繁树的时间序列关联规则分析[J].智能系统学报,2021,16(3):502-510.[16]朱文慧.基于领域驱动数据挖掘的中医治疗糖尿病肾病证-药关系研究[D].北京:北京中医药大学,2019.[17]梁天恺,曾碧,刘建圻.基于FP-Growth的智能家居用户时序关联操控习惯挖掘方法[J].计算机应用研究,2020,37(2):385-389.[18]文芳,黄慧玲,李腾达,等.基于FP-growth关联规则的图书馆数据快速挖掘算法研究[J].重庆理工大学学报(自然科学),2020,34(6):189-194.[19]方晓洁,黄伟琼,叶东华,等.分布式并行FP-growth算法在二次设备缺陷监测中的应用[J].电力系统保护与控制,2021,49(8):160-167.[20]王营,高琦,李婷玉,等.基于改进FP-growth算法的售后服务数据挖掘[J].现代制造工程,2021(6):31-37.[21]蔡云.周仲瑛教授治疗肺癌的知识本体构建与数据挖掘研究[D].广州:广州中医药大学,2019.
相似文献/References:
[1]尤 静.肺癌患者外周血CEA、NSE、CYFRA21-1联合检测的意义[J].医学信息,2018,31(06):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
YOU Jing.Clinical Significance of Combined Detection of CEA,NSE,CYFRA21-1 in Peripheral Blood of Patients with Lung Cancer[J].Medical Information,2018,31(04):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
[2]戴 芳,曹晓美,王莉娜.肺癌患者疾病不确定感的影响因素与干预措施研究现状[J].医学信息,2018,31(08):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
DAI Fang,CAO Xiao-mei,WANG Li-na.Research Status on Influencing Factors and Intervention Measures of Disease Uncertainty in Patients with Lung Cancer[J].Medical Information,2018,31(04):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
[3]吴 倩,王一非.中西医结合治疗肺癌脑转移疗效与安全性的Meta分析[J].医学信息,2022,35(10):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
WU Qian,WANG Yi-fei.Meta-analysis of Efficacy and Safety of Integrated Traditional Chinese and Western Medicine in the Treatment of Brain Metastasis of Lung Cancer[J].Medical Information,2022,35(04):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
[4]王晓军.以时间护理为基础的呼吸训练与排痰管理对肺癌手术患者康复的影响研究[J].医学信息,2022,35(11):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
WANG Xiao-jun.Effect of Respiratory Training and Expectoration Management Based on Time Nursing on Rehabilitation of Patients with Lung Cancer Surgery[J].Medical Information,2022,35(04):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
[5]邢益辉,刘 曼,厉玛倩倩,等.快速康复对肺癌手术患者并发症发生及生活质量的影响研究[J].医学信息,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
XING Yi-hui,LIU Man,LIMA Qian-qian,et al.Effect of Rapid Rehabilitation on Complications and Quality of Life in Patients with Lung Cancer Surgery[J].Medical Information,2018,31(04):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
[6]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Medical Information,2018,31(04):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[7]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Medical Information,2018,31(04):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[8]覃柳麻,何慧敏.2014~2016年广西肿瘤医院肺癌患者流行病学及病理分布特征分析[J].医学信息,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
QIN Liu-ma,HE Hui-min.Epidemiological and Pathological Distribution Characteristics of Lung Cancer Patients in Guangxi Cancer Hospital from 2014 to 2016[J].Medical Information,2019,32(04):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
[9]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Medical Information,2019,32(04):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[10]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Medical Information,2019,32(04):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]